Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edaravone in the Treatment of ALS
IRCT20190324043105N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of edaravone in amyotrophic lateral sclerosis (ALS), sponsored by Isfahan University of Medical Sciences. Started Mar 2017; status: completed.
02
Drugs
edaravone
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on IRCT20190324043105N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190324043105N1.